Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
recombinant antihemophilic factor |
| gptkbp:activeIngredient |
recombinant factor VIII
|
| gptkbp:approvalYear |
1993
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
B02BD02
|
| gptkbp:form |
powder for solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kogenate
|
| gptkbp:indication |
perioperative management in hemophilia A
prevention and control of bleeding in hemophilia A |
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:notRecommendedFor |
gptkb:von_Willebrand_disease
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
headache rash allergic reactions inhibitor development |
| gptkbp:storage |
refrigerate
|
| gptkbp:usedFor |
gptkb:hemophilia_A
|
| gptkbp:bfsParent |
gptkb:Bayer
|
| gptkbp:bfsLayer |
5
|